| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1547626A2 Carrier with solid fibrinogen and solid thrombin |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1545563A1 Composition and method for use in intestinal cleansing procedures |
| 06/29/2005 | EP1545217A1 Induction of gene expression using a high concentration sugar mixture |
| 06/29/2005 | CN1208051C Medicine against spinal canal restenosis and use thereof |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1177200B1 Ligands for metabotropic glutamate receptors |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/15/2005 | EP1539739A1 Piperidinyl compounds that selectively bind integrins |
| 06/15/2005 | EP1539196A1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 06/14/2005 | US6906044 Regeneration of articular cartilage damaged by grade I and II osteoarthritis by means of the intraarticular application of a mixture of sodium hyaluronate and chondroitin sulfate in a gel vehicle |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/08/2005 | EP1432427B1 Composition of hypochlorous acid and its applications |
| 06/08/2005 | EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors |
| 06/08/2005 | EP0850074B1 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 06/08/2005 | CN1623561A Antiadhesion protective preparation and its application |
| 06/08/2005 | CN1623560A Preparation method of antiadhesion protective preparation |
| 06/08/2005 | CN1623559A Anti adhesion protective preparation |
| 06/08/2005 | CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 06/08/2005 | CN1204914C Medicine for preventing and treating intestinal adhesion in abdominal operation, and preparing method thereof |
| 06/07/2005 | US6903199 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/02/2005 | US20050119219 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 06/02/2005 | US20050119216 Pharmaceutical compositions and methods relating to fucans |
| 06/02/2005 | US20050119164 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 06/02/2005 | US20050119162 Anxiolytic agents; using transferrins; quality of life for cancer patients; antiarthritic agents; antiinflammatory agents; compaction; uniform particle size |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 05/26/2005 | US20050112565 Proteases |
| 05/25/2005 | EP1532242A2 Methods for preparing purified prostaglandin e synthase |
| 05/25/2005 | EP1531799A1 Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 05/25/2005 | EP1531791A2 Prevention and reduction of blood loss |
| 05/25/2005 | EP1115434B1 Adhesive protein foam for surgical and/or therapeutic uses |
| 05/25/2005 | CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |
| 05/18/2005 | EP1530466A2 Use of lck inhibitor for treatment of immunologic diseases |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/12/2005 | WO2005016514A3 Combinatorial synthesis on support |
| 05/12/2005 | US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1005337B1 Pharmacologic drug combination in vagal-induced asystole |
| 05/11/2005 | CN1615160A A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/06/2005 | CA2542913A1 Oligopeptides as coating material for medical products |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1330246B1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 04/26/2005 | US6884788 Thiol-modified hyaluronan |
| 04/21/2005 | WO2004081042A3 Identification of pain-relevant genes of a snsr family (specific sensory neurone receptors) |
| 04/20/2005 | EP1318829B1 Angiogenic tri- or tetrapeptides derived from AcSDKP |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/14/2005 | US20050080118 Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/07/2005 | US20050074496 Utilizing such as fucoidan to treat surgical adhesions, arthritis, psoriasis; nontoxic, reduced side effects |
| 04/06/2005 | EP1519962A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 04/06/2005 | CN1195511C The use of fumaric acid derivatives in transplant medicine |
| 04/06/2005 | CN1195495C Emulsion preconcentrate containing cyclosporin or macrolide |
| 03/31/2005 | WO2005027933A1 Unsaturated phosphatidylcholines and uses thereof |
| 03/31/2005 | WO2003018756A3 Methods for preparing purified prostaglandin e synthase |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/30/2005 | EP1181035B1 Substantially oil-free cyclosporin compositions |
| 03/30/2005 | CN1602207A Methods for inhibiting ocular processes |
| 03/30/2005 | CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/24/2005 | WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/23/2005 | EP1343542B1 Carrier with solid fibrinogen and solid thrombin |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/17/2005 | US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/16/2005 | EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 03/16/2005 | EP1513820A2 Compounds, compositions, and methods |
| 03/16/2005 | EP1513545A2 Methods and means to promote gut absorption |
| 03/16/2005 | EP1513495A1 Modified release pharmaceutical formulation |
| 03/16/2005 | CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 03/16/2005 | CN1596109A Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 03/10/2005 | WO2005021011A1 Use of surfactant preparations for the treatment of surgical adhesions |
| 03/10/2005 | WO2003103475A3 Prevention and reduction of blood loss |
| 03/10/2005 | US20050054611 Composition and method for use in intestinal cleansing procedures |
| 03/10/2005 | CA2536453A1 Use of surfactant preparations for the treatment of surgical adhesions |
| 03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 03/09/2005 | CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity |
| 03/08/2005 | US6863885 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 03/02/2005 | EP1296650B1 Methods and compositions for treating pain of the mucous membrane |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 02/24/2005 | WO2005016514A2 Combinatorial synthesis on support |
| 02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
| 02/23/2005 | EP1507559A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 02/23/2005 | CN1585645A Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 02/17/2005 | WO2005013691A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 02/17/2005 | CA2534415A1 Therapeutic delivery of carbon monoxide |
| 02/16/2005 | EP1506013A1 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |